I constantly see people rise in life who are not the smartest, sometimes not even the most diligent, but they are learning machines. They go to bed every night a little wiser than they were when they got up and boy does that help, particularly when you have a long run ahead of you. – Charlie Munger
Welcome to this edition of Integrated BioSci Rounds Report....More>>>
Kodak is moving from cameras to crypto in a move likely to be viewed as a picture-perfect example of bitcoin mania.
The century-old camera brand said Tuesday it is investing in blockchain technology and plans to launch a “photo-centric cryptocurrency” called KODAKCoin.
Kodak (KODK)’s stock surged as much as 125% in trading after the announcement.
Shares ofSangamo Therapeutics (NASDAQ:SGMO) are down 10% as of 1:28 p.m. EDT after the biotech announcedfirst-quarter results this morning, although there doesn’t seem to be any negative news in the release that would justify a double-digit decline.
Perhaps it’s the lack of something extra in the update that has short-term investors hitting the sell button.....More>>>
Baltimore, MD, based Investment company Rothschild Capital Partners, LLC buys SPDR Select Sector Fund – Financial, SPDR S&P Regional Banking, SPDR Select Sector Fund – Health Care, SPDR Series Trust S&P Biotech, Burlington Stores Inc, US Foods Holding Corp, SPDR Select Sector Fund – Industrial, Dollar Tree Inc, SVB Financial Group, SPDR S&P Retail, sells Celgene Corp,....More>>>
Momenta Pharmaceuticals (NASDAQ:MNTA) issued its quarterly earnings results on Tuesday. The biotechnology company reported ($0.63) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.48) by ($0.15), Morningstar.com reports. The firm had revenue of $4.85 million for the quarter, compared to the consensus estimate of $15.63 million. Momenta Pharmaceuticals....More>>>
In response to receiving a Complete Response Letter (CRL) from the FDA, shares of Evolus(NASDAQ:EOLS), a newly public clinical-stage biotech company focused on aesthetics, sank 31% as of 11:05 a.m. EDT on Wednesday.
Evolus announced today thatits lead compound, DWP-450, received a CRL from the FDA, which is a nice way of saying that it was rejected.....More>>>
Investment company Summit X, LLC buys iShares Core MSCI Emerging Markets, iShares Core S&P 500, Pimco Dynamic Credit & Mortgage Income Fund, Pimco Dynamic Credit & Mortgage Income Fund, International Business Machines Corp, iShares 7-10 Year Treasury Bond ETF, iShares S&P 500 Value, iShares Core S&P Mid-Cap, VanEck Vectors Gold Miners, Eversource Energy, sells iShares iBoxx $....More>>>
Shares of Ardelyx (NASDAQ:ARDX) got smacked down 19.5% on Tuesday after announcing that it was raising cash two different ways after the bell yesterday.
Perhaps the biotech would have only been down half as much if it had just stuck with one capital-raising endeavor.
Image source: Getty Images.
First, Ardelyx said it raised $50 million through a....More>>>
Biotech investing has always been an inherently risky business. On top of failed trials, recent political headline risk has added an additional reason for investor concern. Biotech investors may have dodged a bullet with Donald Trump emerging as the victor over Hillary Clinton in the 2016 election but they did not escape totally unharmed. The whole biotech sector was crushed in December 2016 when....More>>>
Gilead Sciences’ (NASDAQ:GILD) last quarterly earnings update in February sounded kind of like a broken record. The news in the fourth quarter of 2017 was very similar to Gilead’s results for earlier quarters in the year.
The big biotech will provide an update on its first-quarter performance on Tuesday, May 1, 2018. Will there be more of thesame old story or some new twists?....More>>>